12:00 AM
 | 
May 04, 2015
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Rosetta Genomics, Admera Health sales and marketing update

Rosetta launched Admera’s laboratory developed test (LDT), OncoGxOne to detects alterations in 64...

Read the full 44 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >